Fig. 2From: SLERT, as a novel biomarker, orchestrates endometrial cancer metastasis via regulation of BDNF/TRKB signalingKnockdown of SLERT inhibits EC migration and invasion. A, B qRT-PCR verifying the knockdown efficiency of these four shRNAs. C CCK-8 assay testing cell viability in control and SLERT-silenced KLE and AN3CA cells. D–G Wound healing and transwell assays testing cell migration and invasion, respectively. H, I Western blot testing the indicated protein levels after knockdown of SLERT. *P<0.05, **P<0.01Back to article page